Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (482) Arrow Down
Filter Results: (482) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (482)
    • People  (1)
    • News  (27)
    • Research  (403)
    • Events  (2)
  • Faculty Publications  (365)

Show Results For

  • All HBS Web  (482)
    • People  (1)
    • News  (27)
    • Research  (403)
    • Events  (2)
  • Faculty Publications  (365)
← Page 14 of 482 Results →
  • May 1999
  • Teaching Note

Elliot Lebowitz TN

By: Paul A. Gompers
Teaching Note for (9-297-094). View Details
Keywords: Biotechnology Industry
Citation
Purchase
Related
Gompers, Paul A. "Elliot Lebowitz TN." Harvard Business School Teaching Note 299-060, May 1999.
  • January 1998 (Revised September 2001)
  • Case

Genset: 1989

By: Paul A. Gompers and Amy Burroughs
Discusses the start-up strategy at Genset, a French biotech firm. Pascal Brandys, a venture capitalist, and Marc Vasseur, a leading French scientist, must decide how to proceed. Future real options are central to the strategy. View Details
Keywords: Strategy; Venture Capital; Business Startups; Biotechnology Industry; France
Citation
Educators
Purchase
Related
Gompers, Paul A., and Amy Burroughs. "Genset: 1989." Harvard Business School Case 298-070, January 1998. (Revised September 2001.)
  • June 1997 (Revised September 1997)
  • Case

Genset Initial Public Offering (B)

By: Paul A. Gompers and Jeffrey M. Anapolsky
Supplements the (A) case. View Details
Keywords: Business Model; Initial Public Offering; Genetics; Going Public; Management Teams; Biotechnology Industry; France; United States
Citation
Educators
Purchase
Related
Gompers, Paul A., and Jeffrey M. Anapolsky. "Genset Initial Public Offering (B)." Harvard Business School Case 297-097, June 1997. (Revised September 1997.)
  • March 2018 (Revised July 2018)
  • Case

Greenlight Biosciences: In Search of Impact Investment

By: Michael Chu, Annelena Lobb and Joni Coughlin
Greenlight Biosciences, a biotech company, is in search of impact investment for its next round of financing. View Details
Keywords: Impact Investment; Investment; Environmental Sustainability; Financing and Loans; Biotechnology Industry
Citation
Educators
Purchase
Related
Chu, Michael, Annelena Lobb, and Joni Coughlin. "GreenLight Biosciences: In Search of Impact Investment." Harvard Business School Case 318-072, March 2018. (Revised July 2018.)
  • November 2016
  • Case

Anthony Starks at InSiL Therapeutics (A)

By: Gary Pisano and Vicki Sato
When Bruce Wayne hired Anthony Starks, he thought he had hit a home run by getting the most brilliant and passionate scientist-leader in the field to be his CSO. But a few months in, Wayne and Starks begin to clash over crucial forward-looking decisions about the... View Details
Keywords: Biotech; Silicon; Managing Innovation; Management Challenges; Managing People; Managing Organization; R&D; R&D Project Management; Platform; Venture Capital; Drug Discovery; management; Biotechnology Industry; California
Citation
Educators
Purchase
Related
Pisano, Gary, and Vicki Sato. "Anthony Starks at InSiL Therapeutics (A)." Harvard Business School Case 617-029, November 2016.
  • January 2012 (Revised August 2012)
  • Case

Dirigo International

By: Christopher M. Gordon and Chad M. Carr
Dirigo International is proposing a major expansion of their life sciences research and manufacturing facilities in the heart of a major city and middle to lower income residential neighborhood. The company and city government are seeking a development solution in the... View Details
Keywords: Production; Property; Expansion; Governing Rules, Regulations, and Reforms; Business and Government Relations; Research and Development; Outcome or Result; Biotechnology Industry
Citation
Educators
Purchase
Related
Gordon, Christopher M., and Chad M. Carr. "Dirigo International." Harvard Business School Case 212-056, January 2012. (Revised August 2012.)
  • August 2010 (Revised August 2012)
  • Supplement

Generation Health: A Pioneer in Genetics Benefit Management (B)

By: Robert F. Higgins
Keywords: Health; Research and Development; Biotechnology Industry
Citation
Purchase
Related
Higgins, Robert F. "Generation Health: A Pioneer in Genetics Benefit Management (B)." Harvard Business School Supplement 811-005, August 2010. (Revised August 2012.)
  • January 2010 (Revised August 2011)
  • Case

Ganeden Biotech, Inc.

By: Robert C. Pozen, Dale Alan Winger and Matthew Kenneth Ahlers
The CEO of Ganeden Biotech, a small firm with several viable probiotic products but limited resources, must decide what markets to invest in and what intellectual property strategies will best serve its immediate and longer-term business interests. View Details
Keywords: Entrepreneurship; Investment; Intellectual Property; Market Entry and Exit; Business Strategy; Biotechnology Industry
Citation
Educators
Purchase
Related
Pozen, Robert C., Dale Alan Winger, and Matthew Kenneth Ahlers. "Ganeden Biotech, Inc." Harvard Business School Case 310-073, January 2010. (Revised August 2011.)
  • November 2009 (Revised March 2010)
  • Case

Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story

By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Citation
Educators
Purchase
Related
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
  • July 2009
  • Teaching Note

Targanta Therapeutics: Hitting a Moving Target (TN)

By: Arthur A. Daemmrich
Teaching Note for [709002]. View Details
Keywords: Governing Rules, Regulations, and Reforms; Product Development; Business Strategy; Initial Public Offering; Mergers and Acquisitions; Policy; Selection and Staffing; Health Testing and Trials; Resource Allocation; Biotechnology Industry
Citation
Purchase
Related
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target (TN)." Harvard Business School Teaching Note 710-006, July 2009.
  • May 2004
  • Teaching Note

Monsanto: Technology Cooperation and Small Holder Farmer Projects (TN)

By: James E. Austin and Diana Barrett
Teaching Note to (9-302-068). View Details
Keywords: Biotechnology Industry
Citation
Purchase
Related
Austin, James E., and Diana Barrett. "Monsanto: Technology Cooperation and Small Holder Farmer Projects (TN)." Harvard Business School Teaching Note 304-108, May 2004.
  • November 2001 (Revised December 2002)
  • Case

Tracking Stocks at Genzyme (A)

By: Malcolm S. Salter
Genzyme, a tracking stock pioneer, has used its innovative capital structure as a way to frame and grow its R&D-intensive business. Facing the question of how best to integrate a new acquisition into its tracking stock structure, Genzyme's top management is forced to... View Details
Keywords: Integration; Value Creation; Motivation and Incentives; Conflict of Interests; Stocks; Capital Structure; Research and Development; Corporate Governance; Biotechnology Industry
Citation
Find at Harvard
Related
Salter, Malcolm S. "Tracking Stocks at Genzyme (A)." Harvard Business School Case 902-023, November 2001. (Revised December 2002.)
  • October 2001 (Revised June 2002)
  • Case

Centagenetix (A): Building a Business Model for Genetic Longevity

Describes a start-up company seeking to exploit population genetic data from long-lived, healthy people. The company must address legal, financial, ethical, and personal issues among its team to launch the company. View Details
Keywords: Ethics; Genetics; Business Startups; Biotechnology Industry
Citation
Educators
Purchase
Related
Chesbrough, Henry W., and Frank Angella. "Centagenetix (A): Building a Business Model for Genetic Longevity." Harvard Business School Case 602-087, October 2001. (Revised June 2002.)
  • April 2001 (Revised January 2003)
  • Case

Robert Shapiro and Monsanto

Traces Monsanto's efforts to become a global biotech powerhouse under Shapiro's leadership. Examines how his crusade to save the world through genetic modification foundered. View Details
Keywords: Genetics; Supply Chain Management; Alliances; Global Strategy; Cross-Cultural and Cross-Border Issues; Biotechnology Industry
Citation
Educators
Purchase
Related
Watkins, Michael D., and Ann Leamon. "Robert Shapiro and Monsanto." Harvard Business School Case 801-426, April 2001. (Revised January 2003.)
  • November 1999
  • Case

Seminis Inc.

By: Ray A. Goldberg, Jonathan West, Carin-Isabel Knoop and David Benedict Pearcy
Seminis became the world leader in vegetable seeds through a series of acquisitions. This case describes the Seminis strategy toward capturing value, biotechnology, and international operations. View Details
Keywords: Business Earnings; Acquisition; Profit; Global Strategy; Corporate Strategy; Valuation; Value Creation; Biotechnology Industry
Citation
Find at Harvard
Related
Goldberg, Ray A., Jonathan West, Carin-Isabel Knoop, and David Benedict Pearcy. "Seminis Inc." Harvard Business School Case 600-030, November 1999.
  • August 1996 (Revised May 1997)
  • Case

Delta & Pine Land: Measuring the Value of Transgenic Cotton

By: Ray A. Goldberg and Charlotte A. Tasker
Discusses the joint venture between two companies with different capabilities: 1) technology provider and 2) transportation agent. Discusses how to capture value from joint venture and biotechnology: 1) who are winners and who are losers; 2) how much value can/should... View Details
Keywords: Agribusiness; Joint Ventures; Marketing Strategy; Supply Chain Management; Performance Consistency; Information Technology; Transportation; Valuation; Biotechnology Industry
Citation
Educators
Purchase
Related
Goldberg, Ray A., and Charlotte A. Tasker. "Delta & Pine Land: Measuring the Value of Transgenic Cotton." Harvard Business School Case 597-005, August 1996. (Revised May 1997.)
  • November 1995 (Revised February 1996)
  • Case

Monsanto Company: The Coming of Age of Bio-Technology

By: Ray A. Goldberg and Thomas N. Urban Jr
Monsanto has one product, Roundup, accounting for 30% of company net income and is going off patent. How should the company position itself and its products in the future? View Details
Keywords: Patents; Product Positioning; Strategic Planning; System Shocks; Biotechnology Industry
Citation
Educators
Purchase
Related
Goldberg, Ray A., and Thomas N. Urban Jr. "Monsanto Company: The Coming of Age of Bio-Technology." Harvard Business School Case 596-034, November 1995. (Revised February 1996.)
  • November 1978 (Revised October 1989)
  • Case

Amicon Corp. (B)

Details the negotiation between Amicon and three potential licensees, Jackson, Maynard-Smith and Behrstein. View Details
Keywords: Technology; Patents; Negotiation Process; Negotiation Participants; Health Care and Treatment; Biotechnology Industry
Citation
Educators
Purchase
Related
Capon, Noel. "Amicon Corp. (B)." Harvard Business School Case 579-094, November 1978. (Revised October 1989.)
  • November 2010 (Revised July 2012)
  • Teaching Note

Arcadia Biosciences: Seeds of Change (TN)

By: Arthur A. Daemmrich and Forest L. Reinhardt
Teaching Note for 709019. View Details
Keywords: Biotechnology Industry
Citation
Purchase
Related
Daemmrich, Arthur A., and Forest L. Reinhardt. "Arcadia Biosciences: Seeds of Change (TN)." Harvard Business School Teaching Note 711-042, November 2010. (Revised July 2012.)
  • 07 Feb 2005
  • Research & Ideas

How “Career Imprinting” Shapes Leaders

Abbott's career imprint could be called a "functional career imprint." Baxter generated a disproportionate number of leaders in the biotechnology industry. During the early 1980s, when the biotech View Details
Keywords: by Mallory Stark
  • ←
  • 14
  • 15
  • …
  • 24
  • 25
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.